TABLE 2  Doses of idebenone used in the NIH phase II trial.^44a

From the following article:

Drug Insight: antioxidant therapy in inherited ataxias

Massimo Pandolfo

Nature Clinical Practice Neurology (2008) 4, 86-96
doi:10.1038/ncpneuro0704

Patient body weight (kg)	Low dose (mg/day)	Middle dose (mg/day)	High dose (mg/day)
aDrug administered in three divided doses (e.g. 450 mg = 150 mg three times daily).
45	180	450	1,350
>45	360	900	2,250

PowerPoint slides for teaching

Downloading may take up to 30 seconds. If the slide opens in your browser, select File > Save As to save it. Download Power Point slide (72K)